The hypermorphic PLCγ2 S707Y variant dysregulates microglial cell function – Insight into PLCγ2 activation in brain health and disease, and opportunities for therapeutic modulation
Authors:
Open Access
- 6 December 2023
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1870 (2) , 166978
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Fidelity Foundation
- Wellcome Trust
- GlaxoSmithKline
- Alzheimer’s Research UK
This publication has 52 references indexed in Scilit:
- Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2Genome Biology, 2014
- Brief Report: Connecting Two Pathways Through Ca2+ Signaling: NLRP3 Inflammasome Activation Induced by a Hypermorphic PLCG2 MutationArthritis & Rheumatology, 2014
- Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor IbrutinibNew England Journal of Medicine, 2014
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic featuresBioinformatics, 2013
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- A Hypermorphic Missense Mutation in PLCG2 , Encoding Phospholipase Cγ2, Causes a Dominantly Inherited Autoinflammatory Disease with ImmunodeficiencyThe American Journal of Human Genetics, 2012
- Regulation of innate immune responses in the brainNature Reviews Immunology, 2009
- LPS/TLR4 signal transduction pathwayCytokine, 2008
- Peptidoglycan and lipopolysaccharide activate PLCγ2, leading to enhanced cytokine production in macrophages and dendritic cellsGenes to Cells, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001